BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker

Edora HF-T QP Completes BIOTRONIK's ProMRI Portfolio LAKE OSWEGO, Ore., Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- BIOTRONIK today announced FDA approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) c... Devices, Cardiology, FDA, Product Launch BIOTRONIK, Edora HF-T QP, cardiac resynchronization therapy, pacemaker
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news